SG Americas Securities LLC Boosts Holdings in CVS Health Corporation $CVS

SG Americas Securities LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 136.0% during the 3rd quarter, Holdings Channel.com reports. The fund owned 64,467 shares of the pharmacy operator’s stock after purchasing an additional 37,148 shares during the quarter. SG Americas Securities LLC’s holdings in CVS Health were worth $4,860,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Harbor Capital Advisors Inc. boosted its position in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the period. Avion Wealth lifted its stake in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health in the second quarter valued at approximately $30,000. Front Row Advisors LLC grew its position in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CVS. Robert W. Baird raised their price objective on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Leerink Partners raised their price target on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 16th. Wolfe Research upped their price objective on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Wells Fargo & Company decreased their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Finally, Raymond James Financial boosted their target price on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Trading Down 0.4%

NYSE:CVS opened at $80.29 on Friday. CVS Health Corporation has a 1 year low of $46.34 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock has a fifty day moving average price of $78.70 and a two-hundred day moving average price of $73.88. The stock has a market capitalization of $101.92 billion, a price-to-earnings ratio of 211.29, a PEG ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.